| Name |
Lamisil 10 mg/g krema |
| Former Name |
Lamisil 1 % krema |
| Marketing Authorisation Number |
HR-H-374155033 |
| Active Substance |
terbinafinklorid |
| Composition |
1 g kreme sadrži 10 mg terbinafinklorida, što je ekvivalentno 8,8 mg terbinafina |
| Pharmaceutical Form |
krema |
| Manufacturer |
Karo Healthcare AB, Stockholm, Švedska |
| Marketing Authorisation Holder |
Karo Healthcare AB, Box 16184, Stockholm, Švedska |
| Marketing Authorisation Date |
30.08.2024 |
| MA Period of Validity |
unlimited |
| Classification Number |
UP/I-530-09/15-02/318 |
| Registration Number |
381-12-01/171-24-69 |
| Prescription |
Medicinal product subject to medical prescription |
| Type of prescription |
Medicinal product on medical prescription for non-renewable delivery
|
| Distribution |
Supply through pharmacies (community) |
| Advertising to general public |
not allowed |
| ATC Code |
D01AE15 |
| Marketing status |
Marketed |
| Shortage status |
No shortage |
| SmPC |
download |
| PL |
download |
